Claims for Patent: 8,883,143

Summary for Patent: 8,883,143

Title:	Treatment of traumatic-induced migraine headache
Abstract:	A method for selection and treatment of externally caused migraine headache, the method includes identifying a patient group having chronic migraine headache; determining the identified patient group, a specific patient with a post traumatic migraine headache; and administering to the selected patient by injection of a therapeutically effective amount of an invertebrate presynaptic neurotoxin in a pharmaceutically safe form to the selected patient\'s head or upper neck; administration preferably being on the sites of the trigeminal cervical system, enabling axonal transport of the neurotoxin from distal to central sites; and the administration preferably comprising extramuscular injection of the neurotoxin of suitable dilution (a) over the aponeurotic fascia to enable the neurotoxin to diffuse into distal sensory nerves, in order to concentrate the neurotoxin over the occipital-parietal-frontal head region, or (b) intra-orally, in a foramina of the sphenopalatine ganglion for enabling diffusion of the neurotoxin to the ganglion, or (c) to emerging exit points of nerves including foraminal sites for enabling the neurotoxin access to concentrated nerve bundles at exit points of the foramina.
Inventor(s):	Binder; William J. (Beverly Hills, CA)
Assignee:
Application Number:	13/986,197
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,883,143
Patent Claims:	1. A method for selection and treatment of externally caused migraine headache, said method comprising: identifying a patient group having migraine headaches; of the identified patient group, determining a specific patient with a post traumatic chronic migraine headache; and administering a therapeutically effective amount of an a suitably diluted Botulinum toxin in a pharmaceutically safe form to the selected patient's head to reduce chronic migraine headaches. 2. The method according to claim 1 wherein the externally caused chronic migraine headache is post-traumatic stress disorder (PTSD). 3. The method according to claim 1 wherein the externally caused chronic migraine headache is traumatic brain injury (TBI). 4. The method according to claim 3 wherein the Botulinum toxin is Botulinum toxin A. 5. The method according to claim 4 wherein the Botulium toxin A is onabotulinumtoxinA. 6. The method according to claim 3 wherein the Botulinum toxin is Botulinum Toxin B. 7. The method according to claim 1 wherein the Botulinum toxin is an Endotoxin. 8. The method of claim 7 wherein the Endotoxin is an endopeptidase.

Details for Patent 8,883,143

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Allergan, Inc.	BOTOX COSMETIC	onabotulinumtoxina	For Injection	103000	12/09/1991		2032-05-23
Allergan, Inc.	BOTOX	onabotulinumtoxina	For Injection	103000	12/09/1991		2032-05-23